AZN logo

AstraZeneca PLC (AZN) Cost of goods sold

annual cost of goods sold:

$13.53B+$1.60B(+13.40%)
December 31, 2024

Summary

  • As of today (August 31, 2025), AZN annual cost of goods sold is $13.53 billion, with the most recent change of +$1.60 billion (+13.40%) on December 31, 2024.
  • During the last 3 years, AZN annual cost of goods sold has fallen by -$1.26 billion (-8.51%).
  • AZN annual cost of goods sold is now -16.71% below its all-time high of $16.25 billion, reached on December 31, 2022.

Performance

AZN Cost of goods sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNincome statement metrics

quarterly cost of goods sold:

$3.63B+$431.48M(+13.48%)
June 30, 2025

Summary

  • As of today (August 31, 2025), AZN quarterly cost of goods sold is $3.63 billion, with the most recent change of +$431.48 million (+13.48%) on June 30, 2025.
  • Over the past year, AZN quarterly cost of goods sold has increased by +$486.48 million (+15.47%).
  • AZN quarterly cost of goods sold is now -37.72% below its all-time high of $5.83 billion, reached on December 31, 2021.

Performance

AZN quarterly cost of goods sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNincome statement metrics

TTM cost of goods sold:

$15.52B+$486.48M(+3.24%)
June 30, 2025

Summary

  • As of today (August 31, 2025), AZN TTM cost of goods sold is $15.52 billion, with the most recent change of +$486.48 million (+3.24%) on June 30, 2025.
  • Over the past year, AZN TTM cost of goods sold has increased by +$2.85 billion (+22.48%).
  • AZN TTM cost of goods sold is now -19.12% below its all-time high of $19.18 billion, reached on June 30, 2022.

Performance

AZN TTM cost of goods sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNincome statement metrics

Cost of goods sold Formula

COGS = Beginning Inventory + Purchases − Ending Inventory

AZN Cost of goods sold Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+13.4%+15.5%+22.5%
3 y3 years-8.5%-9.8%-19.1%
5 y5 years+100.7%+275.1%+141.9%

AZN Cost of goods sold Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-16.7%+13.4%-23.7%+23.3%-19.1%+25.4%
5 y5-year-16.7%+100.7%-37.7%+275.1%-19.1%+173.1%
alltimeall time-16.7%+395.5%-37.7%+964.6%-19.1%+1779.6%

AZN Cost of goods sold History

DateAnnualQuarterlyTTM
Jun 2025
-
$3.63B(+13.5%)
$15.52B(+3.2%)
Mar 2025
-
$3.20B(-32.8%)
$15.03B(+0.4%)
Dec 2024
$13.53B(+13.4%)
$4.76B(+21.4%)
$14.97B(+10.9%)
Sep 2024
-
$3.92B(+24.7%)
$13.51B(+6.6%)
Jun 2024
-
$3.15B(+0.1%)
$12.67B(+1.6%)
Mar 2024
-
$3.14B(-4.6%)
$12.47B(+0.8%)
Dec 2023
$11.93B(-26.6%)
$3.29B(+6.7%)
$12.37B(-4.9%)
Sep 2023
-
$3.09B(+4.8%)
$13.01B(-6.3%)
Jun 2023
-
$2.95B(-3.2%)
$13.89B(-7.2%)
Mar 2023
-
$3.04B(-22.7%)
$14.97B(-8.8%)
Dec 2022
$16.25B(+9.8%)
$3.94B(-0.7%)
$16.41B(-10.4%)
Sep 2022
-
$3.96B(-1.6%)
$18.31B(-4.6%)
Jun 2022
-
$4.03B(-10.3%)
$19.18B(+8.2%)
Mar 2022
-
$4.49B(-23.0%)
$17.73B(+14.1%)
Dec 2021
$14.79B(+106.2%)
$5.83B(+20.5%)
$15.55B(+33.2%)
Sep 2021
-
$4.84B(+87.6%)
$11.67B(+42.4%)
Jun 2021
-
$2.58B(+11.9%)
$8.20B(+24.4%)
Mar 2021
-
$2.30B(+18.0%)
$6.58B(+15.9%)
Dec 2020
$7.17B(+6.4%)
$1.95B(+43.4%)
$5.68B(-12.5%)
Sep 2020
-
$1.36B(+40.6%)
$6.50B(+1.2%)
Jun 2020
-
$968.00M(-30.9%)
$6.42B(-1.2%)
Mar 2020
-
$1.40B(-49.3%)
$6.50B(+5.0%)
Dec 2019
$6.74B(+8.1%)
$2.77B(+115.8%)
$6.19B(+11.8%)
Sep 2019
-
$1.28B(+22.1%)
$5.53B(+2.8%)
Jun 2019
-
$1.05B(-3.8%)
$5.38B(+1.1%)
Mar 2019
-
$1.09B(-48.4%)
$5.32B(-0.2%)
Dec 2018
$6.23B(+7.2%)
$2.11B(+86.8%)
$5.33B(+21.4%)
Sep 2018
-
$1.13B(+14.4%)
$4.39B(-1.6%)
Jun 2018
-
$989.00M(-10.3%)
$4.46B(+1.9%)
Mar 2018
-
$1.10B(-6.0%)
$4.38B(+5.9%)
Dec 2017
$5.82B(+4.4%)
$1.17B(-2.5%)
$4.14B(+1.3%)
Sep 2017
-
$1.20B(+32.5%)
$4.08B(+9.7%)
Jun 2017
-
$907.00M(+6.0%)
$3.72B(-3.5%)
Mar 2017
-
$856.00M(-23.4%)
$3.86B(-3.5%)
Dec 2016
$5.57B(-8.5%)
$1.12B(+32.8%)
$4.00B(-2.9%)
Sep 2016
-
$841.00M(-19.4%)
$4.11B(-4.1%)
Jun 2016
-
$1.04B(+4.8%)
$4.29B(+0.8%)
Mar 2016
-
$995.00M(-19.4%)
$4.26B(-5.1%)
Dec 2015
$6.09B(-17.9%)
$1.24B(+21.3%)
$4.49B(-8.0%)
Sep 2015
-
$1.02B(+0.9%)
$4.88B(-6.7%)
Jun 2015
-
$1.01B(-17.7%)
$5.23B(-5.2%)
Mar 2015
-
$1.23B(-24.5%)
$5.51B(-3.8%)
Dec 2014
$7.42B(+16.3%)
$1.62B(+18.8%)
$5.73B(-17.1%)
Sep 2014
-
$1.37B(+5.6%)
$6.91B(+2.2%)
Jun 2014
-
$1.29B(-10.3%)
$6.76B(+1.3%)
Mar 2014
-
$1.44B(-48.6%)
$6.67B(+3.3%)
Dec 2013
$6.38B(+2.6%)
$2.80B(+129.9%)
$6.46B(+27.8%)
Sep 2013
-
$1.22B(+1.2%)
$5.05B(-0.7%)
Jun 2013
-
$1.21B(-2.0%)
$5.09B(-2.5%)
Mar 2013
-
$1.23B(-12.0%)
$5.22B(-1.2%)
Dec 2012
$6.22B(-8.1%)
$1.40B(+11.3%)
$5.28B(-2.7%)
Sep 2012
-
$1.26B(-5.8%)
$5.42B(-6.2%)
Jun 2012
-
$1.33B(+3.2%)
$5.78B(-2.8%)
Mar 2012
-
$1.29B(-16.3%)
$5.95B(-1.3%)
Dec 2011
$6.77B(-0.9%)
$1.54B(-4.4%)
$6.03B(-4.1%)
Sep 2011
-
$1.61B(+7.6%)
$6.28B(+1.9%)
Jun 2011
-
$1.50B(+9.5%)
$6.17B(+3.1%)
Mar 2011
-
$1.37B(-24.0%)
$5.98B(-3.5%)
DateAnnualQuarterlyTTM
Dec 2010
$6.84B(+7.4%)
$1.80B(+20.3%)
$6.20B(+2.0%)
Sep 2010
-
$1.50B(+14.0%)
$6.08B(+4.4%)
Jun 2010
-
$1.31B(-17.1%)
$5.82B(-0.6%)
Mar 2010
-
$1.58B(-5.8%)
$5.86B(+4.2%)
Dec 2009
$6.36B(-7.1%)
$1.68B(+35.7%)
$5.62B(+15.7%)
Sep 2009
-
$1.24B(-8.3%)
$4.86B(-3.2%)
Jun 2009
-
$1.35B(+0.1%)
$5.02B(-1.8%)
Mar 2009
-
$1.35B(+46.9%)
$5.11B(-2.8%)
Dec 2008
$6.85B(+4.4%)
$919.14M(-34.3%)
$5.26B(+12.7%)
Sep 2008
-
$1.40B(-3.2%)
$4.67B(-0.1%)
Jun 2008
-
$1.44B(-3.5%)
$4.67B(-0.5%)
Mar 2008
-
$1.50B(+359.0%)
$4.70B(+2.0%)
Dec 2007
$6.56B(+12.5%)
$326.00M(-76.8%)
$4.60B(-21.4%)
Sep 2007
-
$1.41B(-4.4%)
$5.86B(+1.1%)
Jun 2007
-
$1.47B(+4.6%)
$5.79B(+1.6%)
Mar 2007
-
$1.40B(-11.0%)
$5.70B(+2.8%)
Dec 2006
$5.83B(+5.3%)
$1.58B(+17.8%)
$5.54B(+3.6%)
Sep 2006
-
$1.34B(-2.7%)
$5.35B(+2.7%)
Jun 2006
-
$1.38B(+10.4%)
$5.21B(+1.3%)
Mar 2006
-
$1.25B(-10.2%)
$5.14B(-3.6%)
Dec 2005
$5.54B(+1.3%)
$1.39B(+15.6%)
$5.34B(-2.0%)
Sep 2005
-
$1.20B(-8.3%)
$5.45B(-1.8%)
Jun 2005
-
$1.31B(-9.0%)
$5.54B(+0.4%)
Mar 2005
-
$1.44B(-4.0%)
$5.53B(+3.6%)
Dec 2004
$5.47B(+22.4%)
$1.50B(+15.3%)
$5.33B(-2.7%)
Sep 2004
-
$1.30B(+0.7%)
$5.48B(+2.3%)
Jun 2004
-
$1.29B(+3.4%)
$5.36B(+3.3%)
Mar 2004
-
$1.25B(-24.3%)
$5.19B(+1.5%)
Dec 2003
$4.47B(-1.1%)
$1.65B(+39.8%)
$5.11B(+2.7%)
Sep 2003
-
$1.18B(+5.2%)
$4.98B(-5.9%)
Jun 2003
-
$1.12B(-4.3%)
$5.30B(+1.0%)
Mar 2003
-
$1.17B(-22.7%)
$5.24B(+0.0%)
Dec 2002
$4.52B(+1.4%)
$1.51B(+1.4%)
$5.24B(+6.2%)
Sep 2002
-
$1.49B(+39.6%)
$4.94B(+9.6%)
Jun 2002
-
$1.07B(-8.5%)
$4.50B(-0.5%)
Mar 2002
-
$1.17B(-3.1%)
$4.53B(+2.4%)
Dec 2001
$4.46B(+6.6%)
$1.21B(+13.8%)
$4.42B(-0.3%)
Sep 2001
-
$1.06B(-2.8%)
$4.43B(-3.1%)
Jun 2001
-
$1.09B(+2.6%)
$4.57B(-14.3%)
Mar 2001
-
$1.06B(-12.8%)
$5.34B(-0.1%)
Dec 2000
$4.18B(+21.4%)
$1.22B(+1.4%)
$5.34B(+44.2%)
Sep 2000
-
$1.20B(-35.2%)
$3.70B(-1.4%)
Jun 2000
-
$1.85B(+73.3%)
$3.76B(+20.8%)
Mar 2000
-
$1.07B(-354.7%)
$3.11B(+52.4%)
Dec 1999
$3.44B(-3.4%)
-$420.00M(-133.5%)
$2.04B(-17.1%)
Sep 1999
-
$1.25B(+3.8%)
$2.46B(+103.8%)
Jun 1999
-
$1.21B(+46.3%)
$1.21B(+46.3%)
Dec 1998
$3.57B(+10.2%)
-
-
Jun 1998
-
$825.50M(-12.9%)
$825.50M(-12.9%)
Dec 1997
$3.24B(-7.8%)
-
-
Dec 1996
$3.51B(+5.8%)
-
-
Dec 1995
$3.32B(+17.8%)
-
-
Jun 1995
-
$947.90M
$947.90M
Dec 1994
$2.82B(-0.5%)
-
-
Dec 1993
$2.83B(-0.3%)
-
-
Dec 1992
$2.84B(+3.9%)
-
-
Dec 1991
$2.73B(-5.6%)
-
-
Dec 1990
$2.89B
-
-

FAQ

  • What is AstraZeneca PLC annual cost of goods sold?
  • What is the all time high annual cost of goods sold for AstraZeneca PLC?
  • What is AstraZeneca PLC annual cost of goods sold year-on-year change?
  • What is AstraZeneca PLC quarterly cost of goods sold?
  • What is the all time high quarterly cost of goods sold for AstraZeneca PLC?
  • What is AstraZeneca PLC quarterly cost of goods sold year-on-year change?
  • What is AstraZeneca PLC TTM cost of goods sold?
  • What is the all time high TTM cost of goods sold for AstraZeneca PLC?
  • What is AstraZeneca PLC TTM cost of goods sold year-on-year change?

What is AstraZeneca PLC annual cost of goods sold?

The current annual cost of goods sold of AZN is $13.53B

What is the all time high annual cost of goods sold for AstraZeneca PLC?

AstraZeneca PLC all-time high annual cost of goods sold is $16.25B

What is AstraZeneca PLC annual cost of goods sold year-on-year change?

Over the past year, AZN annual cost of goods sold has changed by +$1.60B (+13.40%)

What is AstraZeneca PLC quarterly cost of goods sold?

The current quarterly cost of goods sold of AZN is $3.63B

What is the all time high quarterly cost of goods sold for AstraZeneca PLC?

AstraZeneca PLC all-time high quarterly cost of goods sold is $5.83B

What is AstraZeneca PLC quarterly cost of goods sold year-on-year change?

Over the past year, AZN quarterly cost of goods sold has changed by +$486.48M (+15.47%)

What is AstraZeneca PLC TTM cost of goods sold?

The current TTM cost of goods sold of AZN is $15.52B

What is the all time high TTM cost of goods sold for AstraZeneca PLC?

AstraZeneca PLC all-time high TTM cost of goods sold is $19.18B

What is AstraZeneca PLC TTM cost of goods sold year-on-year change?

Over the past year, AZN TTM cost of goods sold has changed by +$2.85B (+22.48%)
On this page